Results 11 to 20 of about 451,760 (295)
Cutaneous leishmaniasis mimicking cutaneous lymphoma [PDF]
IDCases, 2019 Cutaneous leishmaniasis (CL) is caused by protozoa of Leishmania genus that are transmitted to humans through the bite of sand flies (Lutzomyia and Phlebotomus). The infection is classically manifested as multiple or single ulcers affecting cutaneous and/
Carla Andréa Avelar Pires +9 more
doaj +5 more sources
A Unique Presentation of Cutaneous Diffuse Large B-Cell Lymphoma [PDF]
Case Reports in Dermatological Medicine, 2020 Cutaneous B-cell lymphomas (CBCL) are rare heterogeneous neoplastic diseases composing about 22.5% of all cutaneous lymphomas. These diseases can be divided into primary and secondary cutaneous variants with primary cutaneous B-cell lymphoma (PCBCL ...
Mary Awad +2 more
doaj +3 more sources
Care and treatment for primary cutaneous lymphoma-associated ulcers: Two case reports [PDF]
SAGE Open Medical Case ReportsPrimary cutaneous lymphoma is a heterogeneous group of cutaneous lymphocytic primary tumors belonging to the extranodal category of non-Hodgkin lymphoma.
Min Wei +4 more
doaj +2 more sources
Epidemiology of cutaneous lymphoma. [PDF]
Br J Dermatol, 2021 Linked Article: Dobos et al. Br J Dermatol 2021; 184:1059–1067.
Vermeer M.
europepmc +4 more sources
Cutaneous Lymphoma Associated with JAK Inhibitors: A Pharmacovigilance Analysis of the FAERS Database and Literature Review [PDF]
Acta Dermato-VenereologicaThe increasing use of JAK inhibitors in clinical practice is raising concerns regarding the potential risk of cutaneous lymphoma. This study aimed to conduct a comprehensive search for cases of cutaneous lymphoma associated with JAK inhibitors in the ...
Lu Lu +7 more
doaj +2 more sources
Hodgkin's Lymphoma with Cutaneous Involvement
Middle East Journal of Cancer, 2016 Cutaneous Hodgkin’s lymphoma is a rare disease (0.5% to 3.4%) which tends to be in the setting of an advanced disease and has a poor prognosis. Treatment of patients with cutaneous involvement of Hodgkin’s lymphoma is according to dissemination of ...
Ahmad Ameri, Ainaz Sourati
doaj +1 more source
Cells, 2023 Extracorporeal photopheresis (ECP) is an FDA-approved immunotherapy for cutaneous T-cell lymphoma, which can provide a complete response in some patients. However, it is still being determined who will respond well, and predictive biomarkers are urgently
Oleg E. Akilov
doaj +1 more source
Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma
Cells, 2022 The loss of CD47 on aging cells serves as a signal to macrophages to eliminate the target. Therefore, CD47 is a “do-not-eat-me” sign preventing macrophagal phagocytosis via interaction with its ligand SIRPα. Malignant lymphocytes of mycosis fungoides and
Amy Xiao, Oleg E. Akilov
doaj +1 more source
Cutaneous lymphomas – an update
HistopathologyPrimary cutaneous lymphomas (CL) and lymphoproliferative disorders (LPD) are heterogeneous T‐ and B‐cell neoplasms defined by integrated clinical, histopathological, immunophenotypic and genetic criteria. The 5th edition of the WHO classifications of haematolymphoid and skin tumours and the International Consensus Classification incorporate recent ...
Werner Kempf, Christina Mitteldorf
openaire +4 more sources
Reliable blood cancer cells' telomere length evaluation by qPCR
Cancer Medicine, 2020 Background Telomere shortening is linked to a range of different human diseases, hence reliable measurement methods are needed to uncover such associations.
Joana Ropio +10 more
doaj +1 more source